Clinical Trials
43 trialsNCT03941730 2026-05-12
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT05716516 2026-05-05
ESTHER
Dartmouth-Hitchcock Medical Center
Phase 2 Recruiting
NCT06179303 2026-04-16
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT07466498 2026-03-12
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
University of Washington
Phase 2 Not yet recruiting
NCT07379502 2026-01-30
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
CMH Kharian Medical College
Phase NA Not yet recruiting
NCT01984138 2026-01-28
REVIVE
The Methodist Hospital Research Institute
Phase 2 Active not recruiting
NCT03043924 2025-12-11
MRI-PCOS
University Hospital, Lille
Phase NA Completed
NCT00984399 2025-12-09
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05900895 2025-11-20
PHOEBE
Dartmouth-Hitchcock Medical Center
Phase 1 Recruiting
NCT03401047 2025-08-05
CRM009
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT05739136 2025-08-01
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Sumitomo Pharma Switzerland GmbH
Active not recruiting
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02238808 2025-06-26
PRESTO
AHS Cancer Control Alberta
Phase 2 Active not recruiting
NCT00080756 2024-08-28
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
City of Hope Medical Center
Phase 2 Active not recruiting
NCT05168865 2024-02-20
Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.
Dubai Fertility Center
Phase 4 Withdrawn
NCT01425541 2023-11-02
JCM010
University of Virginia
Phase NA Unknown
NCT04597099 2023-11-02
CRM010
University of Virginia
Phase EARLY_PHASE1 Unknown
NCT05243823 2022-12-23
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
Novo Nordisk A/S
Completed
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03049735 2022-04-19
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT01923298 2022-02-10
Estradiol Levels in Patients Treated With Estring
University of Arizona
Phase 2 Completed
NCT05112692 2021-11-09
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Mansoura University
Phase NA Unknown
NCT01441635 2021-07-13
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
AbbVie
Phase 2 Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT01427595 2021-01-08
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
University of Virginia
Phase NA Completed
NCT04002635 2021-01-08
LEFT
CRG UZ Brussel
Phase 4 Withdrawn
NCT01428245 2020-12-30
JCM026
University of Virginia
Phase NA Terminated
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT01817530 2020-07-21
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie
Phase 2 Completed
NCT02654054 2020-06-29
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02455453 2020-01-14
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Washington University School of Medicine
Phase 2 Completed
NCT01083641 2019-12-09
Estrogen for Triple Negative Breast Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT02273791 2018-10-29
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Mansoura University
Completed
NCT01385280 2018-10-17
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
University of Arizona
Phase NA Completed
NCT01428193 2018-06-04
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
University of Virginia
Phase NA Terminated
NCT02528383 2017-09-18
Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors
UConn Health
Phase NA Completed
NCT00661531 2017-04-12
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Georgetown University
Phase 2 Terminated
NCT02352597 2017-03-24
PCOS
Cairo University
Phase 4 Completed
NCT00586898 2016-03-25
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00324259 2015-02-16
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Washington University School of Medicine
Phase 2 Completed
NCT00698035 2014-06-02
E-String
University of California, San Francisco
Phase 2 Completed
NCT00003771 2013-09-20
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01698164 2012-10-02
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Peking Union Medical College Hospital
Phase 4 Unknown